WaveMan · Form 4
Hopper Jonathan Mark insider trades
> Search tickers & screens ⌘K
LIVE

Hopper Jonathan Mark insider trades

Hopper Jonathan Mark has filed 28 Form 4s with the SEC that we hold, all for Vericel Corp (VCEL), as Chief Medical Officer. Across all of them we count 0 purchases worth $0 and 17 sales worth $4.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($564.3K). The largest single trade was a sale of 10,000 shares of Vericel Corp worth $587.2K, dated 2024-12-02. The first filing on our record is dated 2021-07-02 and the latest 2026-06-30.

Vericel Corp (VCEL)

Chief Medical Officer · 30 filings · 17 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-06-30S, sale reported on Form 4134$7.7K2021-07-02
2021-12-20S, sale reported on Form 41,000$40.0K2021-12-22
2021-12-22S, sale reported on Form 45,881$235.7K2021-12-22
2021-12-22S, sale reported on Form 49,000$361.3K2021-12-22
2022-03-01S, sale reported on Form 410,000$414.1K2022-03-03
2022-03-01S, sale reported on Form 46,738$279.4K2022-03-03
2023-11-20S, sale reported on Form 45,000$182.0K2023-11-22
2024-05-20S, sale reported on Form 410,000$499.9K2024-05-21
2024-09-03S, sale reported on Form 410,000$498.3K2024-09-05
2024-12-02S, sale reported on Form 410,000$587.2K2024-12-03
2025-03-03S, sale reported on Form 410,000$495.3K2025-03-05
2025-06-02S, sale reported on Form 410,000$400.9K2025-06-04
2025-09-02S, sale reported on Form 410,000$357.7K2025-09-03
2025-12-02S, sale reported on Form 41,652$64.7K2025-12-04
2026-04-02S, sale reported on Form 43,472$121.5K2026-04-06
2026-06-02S, sale reported on Form 44,375$153.1K2026-06-04
2026-06-26S, sale reported on Form 45,000$225.0K2026-06-30
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1626325) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms